• Burning Rock posted Q2 2026 revenue of RMB 134.7 million, down 9.3% year-on-year, up 24.8% quarter-on-quarter.
• In-hospital business revenue reached RMB 67.1 million, up 7.4% year-on-year, up 27.3% quarter-on-quarter.
• Cash, cash equivalents, restricted cash totaled RMB 419.1 million as of June 30, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Burning Rock Biotech Ltd. published the original content used to generate this news brief on September 11, 2026, and is solely responsible for the information contained therein.